St. Christopher’s Hospital for Children announced its third leadership change in less than two yearsA new $50 million investment fund will back Penn life sciences start-upsAlveus Therapeutics, a Philadelphia start-up treating obesity, debuted with $160M in fundingS&P downgraded ChristianaCare’s credit ratingDrug distribution giant Cencora is boosting its reach in medical specialtiesCalifornia biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia Drexel University signed a lease to consolidate medical college research in University CityChristianaCare and Virtua Health have ended merger talksWhy Philadelphia loses promising biotech firms to Boston, San Francisco, and San DiegoBancroft, a South Jersey provider of IDD services, hired Gregory Passanante as its next CEO
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
